HALO
Halozyme Therapeutics Inc
109.80$
-0.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -139.2% | -63.6% | -193.5% | – | -10,216.4% | 721.1% | -3.9% | -403.6% | -293.7% | -333.1% | -61.2% | -152.0% | -90.0% | -63.1% | -27.5% | -34.3% | 42.3% | -32.6% | -43.6% | 20.7% | 67.5% | 36.4% | 46.9% | 47.2% | 46.7% | |
| – | – | – | – | 162.2% | 24.9% | 15.2% | 12.0% | 10.6% | 11.1% | 2.0% | 2.6% | 2.2% | 2.3% | 1.2% | 1.6% | 0.7% | 1.6% | 2.1% | 1.2% | 0.7% | 7.5% | 10.2% | 8.0% | 6.3% | |
| – | – | – | – | – | – | – | 42.2% | 33.1% | 35.7% | 9.9% | 19.7% | 17.4% | 20.3% | 15.4% | 17.4% | 9.7% | 23.5% | 17.7% | 6.4% | 4.7% | 3.7% | 4.4% | 4.3% | 3.7% | |
| – | – | – | – | – | – | – | – | – | – | 9.9% | 19.8% | 17.4% | 20.6% | 16.1% | 22.7% | 14.7% | 23.5% | 18.4% | 6.1% | -25.6% | 10.2% | – | – | – | |
| 13.3% | 8.1% | 105.1% | – | -88.4% | 2,067.7% | 541.9% | 97.3% | 89.5% | 10.8% | -37.9% | -47.8% | 40.3% | 0.1% | -21.8% | 11.6% | 6.5% | -3.9% | -25.8% | -40.5% | 0.8% | -16.7% | -4.7% | -13.4% | -10.9% | |
| 0.0% | 0.0% | 0.0% | – | 275.8% | 37.2% | 62.3% | 13.2% | 10.7% | 4.7% | 1.5% | 3.3% | 4.2% | 1.8% | 1.7% | 2.1% | 0.4% | 3.1% | 2.1% | 0.9% | 0.3% | 0.7% | 1.8% | 1.1% | 0.5% | |
| – | – | – | – | -275.8% | -37.2% | -62.3% | -13.2% | -10.7% | -4.7% | -1.5% | -3.3% | -87.4% | -43.7% | 4.4% | -52.3% | -51.7% | 1.6% | -2.8% | 29.3% | -91.6% | -73.8% | -11.7% | -25.9% | -39.1% | |
| – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 7.3% | 23.7% | 2.8% | – | 1.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | 8.5% | 196.5% | 9.3% | 152.0% | 9.7% | 1.3% | 46.6% | 9.0% | -102.0% | -56.1% | -79.0% | -30.3% | -48.5% | -24.6% | -24.5% | |
| – | – | – | – | – | – | – | – | – | – | – | 70.1% | 36.5% | 197.5% | 110.1% | 101.4% | -5.1% | -51.0% | 173.0% | -7.3% | 93.8% | 93.5% | -1.6% | 0.0% | 32.3% | |
| 245.1% | 144.6% | – | – | 12,948.5% | 1,868.3% | 1,473.9% | 29.3% | 331.8% | 453.8% | 8.5% | 266.5% | 45.7% | 152.0% | 9.7% | 102.7% | 41.6% | -42.0% | 78.2% | -39.7% | 17.6% | 54.9% | -49.2% | -21.6% | -6.1% | |
| 105.8% | 81.0% | -193.5% | – | 2,456.2% | 2,552.3% | 1,407.8% | -387.5% | 27.4% | 115.9% | -54.3% | 111.2% | -131.7% | 45.2% | -13.4% | 16.0% | 32.2% | -73.0% | 31.8% | 10.3% | -6.5% | 17.5% | -14.0% | -0.2% | 1.5% | |
| -139.2% | -63.6% | -193.5% | – | -10,492.3% | 684.0% | -66.1% | -416.9% | -304.4% | -337.9% | -62.7% | -155.3% | -94.2% | -64.9% | -29.2% | -36.5% | 41.9% | -35.7% | -45.6% | 19.8% | 67.2% | 35.6% | 45.0% | 46.1% | 46.2% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.